Advertising Console

    Regulation

    Repost
    genetic_alliance

    by genetic_alliance

    0
    4 views
    This panel will consider the effect of regulation on the appropriate use of genetic testing and their integration into healthcare. It will examine the challenges of regulating an industry with several agencies overseeing various aspects, and growth in genetics exceeding the capacity of the expertise of the oversight agencies. Are there gaps in oversight between FDA and CLIA and if so, how do they affect patients? How can they be addressed?

    Moderator: Sheila Walcoff, Goldbug Strategies
    Alberto Gutiérrez, FDA
    Paul Radensky, McDermott Will & Emery
    Alan Mertz, American Clinical Laboratory Association
    Russell Enns, Cepheid.